Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00007657 · ClinicalTrials.gov registry record · Phase 3
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,260
- Enrollment target
NCT00007657 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 3,260 participants.
The verdict
NCT00007657, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,260 participants
- Enrollment target
Study Summary
PCI (optimal catheter-based coronary revascularization) + intensive medical therapy is superior to intensive medical therapy alone using the combined endpoint of all-cause mortality or nonfatal MI.
Interventions
- PROCEDURE Intensive medical therapy
- PROCEDURE Percutaneous Coronary Intervention (PCI) plus intensive medical therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,260 participants |
| Start Date | 1998-12 |
| Est. Completion | 2006-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00007657
The ClinicalTrials.gov registry entry for NCT00007657 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 3,260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intensive medical therapy is the first listed.
NCT00007657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00007657 about?
NCT00007657 is a clinical study titled "Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation". PCI (optimal catheter-based coronary revascularization) + intensive medical therapy is superior to intensive medical therapy alone using the combined endpoint of all-cause mortality or nonfatal MI.
What is the current status of trial NCT00007657?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,260 participants. The study started on 1998-12. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00007657?
The interventions under investigation include: Intensive medical therapy (PROCEDURE), Percutaneous Coronary Intervention (PCI) plus intensive medical therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00007657?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.